(Q43040481)

12 November 2017

Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA. (English)

1 reference

12 November 2017

13

Susan Stramer

1 reference

12 November 2017

Janet Vargo

1

1 reference

12 November 2017

Katie Smith

2

1 reference

12 November 2017

Caroline Knott

3

1 reference

12 November 2017

Songbai Wang

4

1 reference

12 November 2017

Chyang Fang

5

1 reference

12 November 2017

Sherrol McDonough

6

1 reference

12 November 2017

Cristina Giachetti

7

1 reference

12 November 2017

Sally Caglioti

8

1 reference

12 November 2017

Richard Gammon

9

1 reference

12 November 2017

Denise Gilbert

10

1 reference

12 November 2017

J Brooks Jackson

11

1 reference

12 November 2017

William Richards

12

1 reference

12 November 2017

Larry Mimms

14

1 reference

12 November 2017

1 July 2002

1 reference

12 November 2017

1 reference

12 November 2017

42

1 reference

12 November 2017

7

1 reference

12 November 2017

876-885

1 reference

Sensitive detection of genetic variants of HIV-1 and HCV with an HIV-1/HCV assay based on transcription-mediated amplification

12 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00130.X

Validation of HCV-NAT assays and experience with NAT application for blood screening in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00130.X

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00130.X

HCV-RNA screening in a medium size Italian transfusion service using a commercial PCR method: one year's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00130.X

Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00130.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00130.X

Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00130.X

Immune response to blood transfusion invery-low-birthweight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00130.X

Significant closure of the human immunodeficiency virus type 1 and hepatitis C virus preseroconversion detection windows with a transcription-mediated-amplification-driven assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00130.X

10.1046/J.1537-2995.2002.00130.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference